gw8510 has been researched along with Breast Cancer in 1 studies
GW8510: 3' substituted indolone as a scaffold for the development of neuroprotective drug; structure in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "Tamoxifen resistance is a major roadblock in the treatment of patients with breast cancer." | 3.96 | Acquired tamoxifen resistance is surmounted by GW8510 through ribonucleotide reductase M2 downregulation-mediated autophagy induction. ( Chen, CG; Li, J; Li, MY; Li, XQ; Li, ZN; Shu, Y; Wang, S; Zhao, XH, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, ZN | 1 |
| Shu, Y | 1 |
| Chen, CG | 1 |
| Li, XQ | 1 |
| Li, MY | 1 |
| Zhao, XH | 1 |
| Wang, S | 1 |
| Li, J | 1 |
1 other study available for gw8510 and Breast Cancer
| Article | Year |
|---|---|
Acquired tamoxifen resistance is surmounted by GW8510 through ribonucleotide reductase M2 downregulation-mediated autophagy induction.
Topics: Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Autophagy; | 2020 |